Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario

Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario

Immunomodulatory and immunosuppressive therapy is needed in people with a chronic neuroinflammatory disease of the central nervous system such as multiple sclerosis (MS). Therefore, MS requires monitoring for and preventing against infectious diseases like SARS-CoV-2. Vaccination and anti-viral trea...

Full description

Bibliographic Details
Main Authors: Muriel Schraad, Stefan Runkel, Walter Hitzler, Maria Protopapa, Stefan Bittner, Timo Uphaus, Frauke Zipp
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Vaccines
Subjects:
SARS-CoV-2
vaccination
multiple sclerosis
efficiency
booster vaccination
sphingosine-1-phopshate receptor modulator
Online Access:https://www.mdpi.com/2076-393X/12/3/296

Internet

https://www.mdpi.com/2076-393X/12/3/296

Similar Items